Drug Type Synthetic peptide |
Synonyms BMS 234475, BMS-234475, CGP 61755 + [1] |
Target |
Mechanism HIV-1 pol inhibitors(Human immunodeficiency virus type 1 protease inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H53N3O9 |
InChIKeyBEUUJDAEPJZWHM-COROXYKFSA-N |
CAS Registry175385-62-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Lasinavir | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | US | - | |
HIV Infections | Phase 1 | - | - |